Clinical Performance Evaluation of Pefakit® PiCT® UC In Vitro Diagnostic Medical Device
Sponsor: dsm-firmenich Switzerland AG
A observational or N/A phase clinical study on Thromboembolic Events, this trial is completed. The trial is conducted by dsm-firmenich Switzerland AG and has accumulated 11 data snapshots since 2012. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.
Status Flow
Change History
11 versions recorded-
Mar 2026 — Present [monthly]
Completed
-
Sep 2025 — Mar 2026 [monthly]
Completed
-
Sep 2024 — Sep 2025 [monthly]
Completed
-
Jul 2024 — Sep 2024 [monthly]
Completed
-
Jan 2023 — Jul 2024 [monthly]
Completed
▶ Show 6 earlier versions
-
Dec 2022 — Jan 2023 [monthly]
Completed
-
Jan 2021 — Dec 2022 [monthly]
Completed
-
Jun 2018 — Jan 2021 [monthly]
Completed
-
Apr 2018 — Jun 2018 [monthly]
Completed
Phase: NA → None
-
Feb 2017 — Apr 2018 [monthly]
Completed NA
-
Jan 2017 — Feb 2017 [monthly]
Completed NA
First recorded
Apr 2012
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- dsm-firmenich Switzerland AG
For direct contact, visit the study record on ClinicalTrials.gov .